Vision loss due to macular edema induced by rosiglitazone treatment of diabetes mellitus.
Colucciello
Michael
M
South Jersey Eye Physicians, 509 S. Lenola Road, Ste. 11, Moorestown, NJ 08057, USA. michael@macula.us
D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005451:Fluorescein Angiography; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D008269:Macular Edema / Q000139:chemically induced* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000009:adverse effects*; D014786:Vision Disorders / Q000139:chemically induced* / Q000503:physiopathology
D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077154:Rosiglitazone